Free Trial
NYSEARCA:LABD

Direxion Daily S&P Biotech Bear 3x Shares (LABD) Price, Holdings, & News

$5.56
+0.04 (+0.72%)
(As of 09/18/2024 ET)

About Direxion Daily S&P Biotech Bear 3x Shares (NYSEARCA:LABD)

Key Stats

Today's Range
$5.20
$5.63
50-Day Range
$5.38
$7.28
52-Week Range
$5.20
$29.92
Volume
25.47 million shs
Average Volume
15.32 million shs
Market Capitalization
$62.94 million
Assets Under Management
$101.04 million
Dividend Yield
1.62%
Net Expense Ratio
1.10%
Aggregate Rating
N/A

ETF Overview

The Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is managed by Direxion.

Direxion Daily S&P Biotech Bear 3x Shares Expenses

TypeLABDHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.75%0.56%0.55%0.51%0.52%
Other Expenses0.37%0.33%0.49%0.58%0.54%
Total Expense1.12%0.71%0.71%0.73%0.71%
Fee Waiver-0.02%-0.45%-0.52%-0.68%-0.58%
Net Expense1.10%0.61%0.61%0.58%0.59%
Receive LABD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bear 3x Shares and its competitors with MarketBeat's FREE daily newsletter.

LABD ETF News Headlines

Direxion Daily S&P Biotech Bear 3X ETF (LABD)
Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”
Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.
See More Headlines

LABD ETF - Frequently Asked Questions

Direxion Daily S&P Biotech Bear 3x Shares' stock was trading at $9.69 at the beginning of the year. Since then, LABD stock has decreased by 42.6% and is now trading at $5.56.
View the best growth stocks for 2024 here
.

Direxion Daily S&P Biotech Bear 3x Shares shares reverse split on the morning of Friday, August 28th 2020. The 1-20 reverse split was announced on Monday, July 27th 2020. The number of shares owned by shareholders was adjusted after the market closes on Thursday, August 27th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Top institutional investors of Direxion Daily S&P Biotech Bear 3x Shares include Virtu Financial LLC (7.50%), Susquehanna International Group LLP and Scientech Research LLC (0.16%).

Shares of LABD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily S&P Biotech Bear 3x Shares investors own include Direxion Daily S&P Biotech Bull 3x Shares (LABU), Micron Technology (MU), Intel (INTC), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO) and NVIDIA (NVDA).

Fund Details

Issuer
Direxion
Fund Name
Direxion Daily S&P Biotech Bear 3x Shares
Tax Classification
Regulated Investment Company
Current Symbol
NYSEARCA:LABD
Inception Date
5/28/2015
Fund Manager
Paul Brigandi, Tony Ng
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
S&P Biotechnology Select Industry Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
10

Fund Statistics

Assets Under Management
$101.04 million
Average Daily Volume
$15.94 million
Discount/Premium
-0.01%
Leveraged
-3.00

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Rafferty Asset Management, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Foreside Fund Services, LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
3,735
Put Options
389
Call Options
3,346
Short Interest
1,650,000 shs

Miscellaneous

Beta
-3.24
Creation Unit
50,000
Creation Fee
$250.00
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Top 10 LABD Holdings

  • GOLDMAN FINL SQ TRSRY INST 506
    Holding Weight: 48.89%
  • DREYFUS GOVT CASH MAN INS
    Holding Weight: 39.31%
  • GOLDMAN SACHS FIN GOV 465 INSTITUT
    Holding Weight: 11.33%
  • DREYFUS TRSRY SECURITIES CASH MGMT
    Holding Weight: 2.73%
  • S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
    Holding Weight: -11.80%
  • S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
    Holding Weight: -24.62%
  • S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
    Holding Weight: -46.65%
  • S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
    Holding Weight: -59.09%
  • S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
    Holding Weight: -69.79%
  • S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP
    Holding Weight: -88.06%

This page (NYSEARCA:LABD) was last updated on 9/18/2024 by MarketBeat.com Staff
From Our Partners